Skip to main content

Table 1 Baseline characteristics of the IFNα1b group and the control group (FAS)

From: Efficacy and safety of aerosol inhalation of recombinant human interferon α1b (IFNα1b) injection for noninfluenza viral pneumonia, a multicenter, randomized, double-blind, placebo-controlled trial

 

IFNα1b Group

Control Group

P

76

87

Sex

Female

21 (27.6%)

47 (54.0%)

0.001

Male

55 (72.4%)

40 (46.0%)

 

Age

 

55.230 ± 18.950

51.860 ± 19.528

0.268

BMI

 

24.306 ± 3.034

23.814 ± 3.179

0.380

Time of onset (days)

 

5.3 ± 4.2

4.7 ± 2.7

0.239

Back to article page

Journal of Inflammation

ISSN: 1476-9255

Contact us